Public Workspaces

Title Approval of 455-2i30r1 - Sec 4.6.18 Serious Adverse Events
Description 
Proposed revision to NSF/ANSI 455-2 – Good Manufacturing Practices for Dietary Supplements (455-2i30r1)

The purpose of this issue paper is to add a serious adverse event reporting procedure requirement.
Ballot Options Ballot has closed
[ ] Affirmative
[ ] Negative
[ ] Abstain
Document for Approval 455-2i30r1 - Sec 4.6.18 Serious Adverse Events - JC Memo & Ballot.pdf
Opening Date Thu, Apr 28 2022 10:00 am Eastern Daylight Time
Closing Date Thu, May 19 2022 11:59 pm Eastern Daylight Time
Ballot has closed.

Referenced Items

Name Type Date Actions

07621: Approval of 455-2i30r1 - Sec 4.6.18 Serious Adverse Events

Document (Archive)

2022-05-20

 No Access

gmpDS-2021-20 - Sec 4.6.18 Serious Adverse Events.pdf

Document

2022-04-27

 No Access

Blank Comment - TEMPLATE.docx

Document

2022-04-27

 No Access

455-2i30 - 2021 GMP-DS JC Meeting Summary Excerpt.pdf

Document

2022-04-27

 No Access